Evidence map›Paper›PMID 38072216›Full record

ArticlePharmacological research2024

Disease2Vec: Encoding Alzheimer's progression via disease embedding tree.

Lu Zhang, Li Wang, Tianming Liu, Dajiang Zhu

Abstract read
In one paragraph

Article in Pharmacological research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. A Unified Continuous Staging Framework for Alzheimer's Disease and Lewy Body Dementia via Hierarchical Anatomical Features.Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Lu ZhangDepartment of Computer Science and Engineering, The University of Texas at Arlington, Arlington, TX, USA.
Li WangDepartment of Mathematics, The University of Texas at Arlington, Arlington, TX, USA.
Tianming LiuDepartment of Computer Science, The University of Georgia, Athens, GA, USA.
Dajiang ZhuDepartment of Computer Science and Engineering, The University of Texas at Arlington, Arlington, TX, USA. Electronic address: dajiang.zhu@uta.edu.

Funding

Mapping Trajectories of Alzheimer's Progression via Personalized Brain Anchor-nodesR01AG075582 · NIA · UNIVERSITY OF TEXAS ARLINGTON · PI Gang Li, Dajiang Zhu · 2022 to 2026
$2.7M
Developing an Individualized Deep Connectome Framework for ADRD AnalysisRF1NS128534 · NINDS · UNIVERSITY OF TEXAS ARLINGTON · PI LI, GANG, LIU, TIANMING · 2022 to 2022
$1.7M
NIA NIH HHS R01 AG075582NINDS NIH HHS RF1 NS128534
6 · The paper itself

Abstract

For decades, a variety of predictive approaches have been proposed and evaluated in terms of their prediction capability for Alzheimer's Disease (AD) and its precursor - mild cognitive impairment (MCI). Most of them focused on prediction or identification of statistical differences among different clinical groups or phases, especially in the context of binary or multi-class classification. The continuous nature of AD development and transition states between successive AD related stages have been typically overlooked. Though a few progression models of AD have been studied recently, they were mainly designed to determine and compare the order of specific biomarkers. How to effectively predict the individual patient's status within a wide spectrum of continuous AD progression has been largely understudied. In this work, we developed a novel learning-based embedding framework to encode the intrinsic relations among AD related clinical stages by a set of meaningful embedding vectors in the latent space (Disease2Vec). We named this process as disease embedding. By Disease2Vec, our framework generates a disease embedding tree (DETree) which effectively represents different clinical stages as a tree trajectory reflecting AD progression and thus can be used to predict clinical status by projecting individuals onto this continuous trajectory. Through this model, DETree can not only perform efficient and accurate prediction for patients at any stages of AD development (across five fine-grained clinical groups instead of typical two groups), but also provide richer status information by examining the projecting locations within a wide and continuous AD progression process. (Code will be available: https://github.com/qidianzl/Disease2Vec.).

Indexed as

Alzheimer DiseaseCognitive DysfunctionBiomarkersDisease ProgressionHumansBiomarkersAD ProgressionDisease EmbeddingDisease Embedding Tree

Identifiers

PMID38072216
PMCPMC11334056

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.